Q1 2021 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2021-05-06 | ||||||
REV |
Q4 2020 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2021-03-19 | ||||||
REV |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
Ticker | Company | Price | Change | Chg % | Mkt Cap | |
---|---|---|---|---|---|---|
GRTS | Gritstone Oncology | 13.57 | -0.02 | -0.15% | 662.1M |
You can purchase shares of Gritstone Oncology (NASDAQ: GRTS) through any online brokerage.
Other companies in Gritstone Oncology’s space includes: KalVista Pharmaceuticals (NASDAQ:KALV), Chinook Therapeutics (NASDAQ:KDNY) and Adaptimmune Therapeutics (NASDAQ:ADAP).
The latest price target for Gritstone Oncology (NASDAQ: GRTS) was reported by Baird on 2021-01-20. The analyst firm set a price target for 8.00 expecting GRTS to fall to within 12 months (a possible -41.05% downside). 3 analyst firms have reported ratings in the last year.
The stock price for Gritstone Oncology (NASDAQ: GRTS) is $13.57 last updated Fri Mar 05 2021 21:00:02 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Gritstone Oncology.
There is no upcoming split for Gritstone Oncology.